Accelerate Your Clinical Trials with Opportunities in Australia

Description

Australia is a destination of choice for early-phase clinical studies due to its fast and pragmatic regulatory environment, internationally recognized quality systems, and cost competitiveness.

By engaging with Australia for your clinical trials, you will generate data for regulatory approvals at lower cost, via a generous R&D tax incentive scheme. Hear from a successful local company, Etira about their experience with Australian clinical trials. Join BioNTX as we welcome an Australian delegation visiting Dallas who will introduce us to this value. 

Thank you for your support